Current Report Filing (8-k)
January 12 2023 - 08:11AM
Edgar (US Regulatory)
0001899287FALSEfalse000189928700018992872023-01-072023-01-070001899287us-gaap:CommonStockMember2023-01-072023-01-070001899287ampx:RedeemableWarrantsMember2023-01-072023-01-07
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
_________________________
FORM 8-K
_________________________
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): January 7,
2023
_________________________
Amprius Technologies, Inc.
(Exact name of Registrant as Specified in Its Charter)
_________________________
|
|
|
|
|
|
|
|
|
Delaware |
001-41314 |
98-1591811 |
(State or Other Jurisdiction
of Incorporation)
|
(Commission
File Number)
|
(IRS Employer
Identification No.)
|
|
|
|
|
|
|
1180 Page Ave
Fremont, California
|
94538
|
(Address of Principal Executive Offices) |
(Zip Code) |
Registrant’s Telephone Number, Including Area Code: (800)
425-8803
N/A
(Former Name or Former Address, if Changed Since Last
Report)
_________________________
Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant
under any of the following provisions:
|
|
|
|
|
|
|
|
|
|
o |
Written communications pursuant to Rule 425 under the Securities
Act (17 CFR 230.425) |
|
|
|
|
o |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act
(17 CFR 240.14a-12) |
|
|
|
|
o |
Pre-commencement communications pursuant to Rule 14d-2(b) under the
Exchange Act (17 CFR 240.14d-2(b)) |
|
|
|
|
o |
Pre-commencement communications pursuant to Rule 13e-4(c) under the
Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of the
Act:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Title of each class |
|
Trading
Symbol(s) |
|
Name of each exchange
on which registered |
Common stock, par value $0.0001 per share |
|
AMPX |
|
The New York Stock Exchange |
Redeemable warrants, each exercisable for one share of common stock
at an exercise price of $11.50 |
|
AMPX.W |
|
The New York Stock Exchange |
Indicate by check mark whether the registrant is an emerging growth
company as defined in Rule 405 of the Securities Act of 1933
(§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange
Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company
x
If an emerging growth company, indicate by check mark if the
registrant has elected not to use the extended transition period
for complying with any new or revised financial accounting
standards provided pursuant to Section 13(a) of the Exchange
Act.
o
Item 5.02 Departure of Directors or Certain Officers; Election of
Directors; Appointment of Certain Officers; Compensatory
Arrangements of Certain Officers.
On January 7, 2023, following the recommendation of the
Compensation Committee (the “Compensation Committee”) of the board
of directors (the “Board”) of Amprius Technologies, Inc. (the
“Company”), the Board approved annual bonuses for the year ended
December 31, 2022 (the “2022 Bonuses”) for the Company’s executive
officers as set forth below:
|
|
|
|
|
|
Name
|
2022 Bonus
|
Dr. Kang Sun
|
$370,875
|
Sandra Wallach
|
$155,756
|
Dr. Ionel Stefan
|
$150,075
|
Each executive officer’s 2022 Bonus is equal to the amount of the
bonus the executive officer would have received for the year ended
December 31, 2022 if the executive officer’s increased annual base
salary and target annual bonus described below had become effective
on September 16, 2022, plus an amount equal to the base salary the
executive officer would have received for the period beginning on
September 16, 2022, and ending on December 31, 2022, if the
executive officer’s increased annual base salary described below
had become effective on September 16, 2022.
The 2022 Bonuses will be paid on or before January 31, 2023,
provided in each case that the applicable executive officer remains
an employee of the Company through the date that the 2022 Bonuses
are paid.
Additionally, on January 7, 2023, following the recommendation of
the Compensation Committee, the Board approved, effective January
1, 2023, increases in base salary and target annual bonuses for the
Company’s executive officers. The new base salary and target annual
bonuses for the Company’s executive officers are set forth
below:
|
|
|
|
|
|
|
|
|
Name
|
Base Salary, Effective 1/1/2023
|
Target Annual Bonus
(% of Base Salary), Effective 1/1/2023
|
Dr. Kang Sun
|
$624,000
|
100%
|
Sandra Wallach
|
$373,000
|
65%
|
Dr. Ionel Stefan
|
$364,000
|
60%
|
The executive officers’ annual bonus opportunities will be governed
by and subject to the Company’s Executive Incentive Compensation
Plan. In accordance with the Company’s Executive Incentive
Compensation Plan, the performance goals for the executive
officers’ annual bonus opportunities for the year ended December
31, 2023, will be developed by the Compensation Committee and
approved by the Board, and the Board will determine whether and to
what extent such performance goals are achieved.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of
1934, the registrant has duly caused this report to be signed on
its behalf by the undersigned hereunto duly
authorized.
|
|
|
|
|
|
|
|
|
|
|
AMPRIUS TECHNOLOGIES, INC. |
|
|
|
Date: January 12, 2023
|
By: |
/s/ Sandra Wallach |
|
|
Name: Sandra Wallach |
|
|
Title: Chief Financial Officer |
Amprius Technologies (NYSE:AMPX)
Historical Stock Chart
From Mar 2023 to Mar 2023
Amprius Technologies (NYSE:AMPX)
Historical Stock Chart
From Mar 2022 to Mar 2023